™Your Policy Risk Impact Agent
35 chapters · 1,789 sections in this title.
ORS 689.811 Publicly accessible short-acting opioid antagonist; administration; liability; rules
2.0K chars
(1) As used in this section, “kit,” “opioid,” “opioid overdose” and “short-acting opioid antagonist” have the meanings given those terms in ORS 689.800. (2) The owner of any building or facility to which the public has legal access may have in the building or facility one or more…
ORS 689.813 Exemption from drug labeling requirements
1.3K chars
(1) A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Dru…
ORS 689.818 Manufacturer and third party prohibitions related to 340B drugs
1.7K chars
(1) As used in this section: (a) “Covered entity” has the meaning given that term in 42 U.S.C. 256b(a)(4). (b) “Manufacturer” has the meaning given that term in ORS 646A.689. (c) “340B drug” means a drug that has been subject to an offer of a reduced price by a manufacturer pursu…
ORS 689.820 Violation; civil penalty
0.5K chars
(1) In addition to any other liability or penalty provided by law, the State Board of Pharmacy may impose a civil penalty for any violation of ORS 689.818. A civil penalty imposed under this section may not exceed $5,000 per day on a manufacturer for each violation. (2) All penal…